NP / PA
Jones, Marcia
Jones, Marcia was paid $17K by Medicaid between Dec 2018 and Feb 2024, across 10 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoJONES, MARCIA
CUMBERLAND, MD 21502
CUMBERLAND, MD 21502
33aNPI1932357324assigned 08/28/2008
33bProvider typeFamily Nurse Practitioner
28Total paid$17K
24GClaims562
24DCodes billed10
24AFirst – last monthDec 2018 – Feb 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Maryland
Rank by total paid#112 of 195
Median peer was paid$25K
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 36 | $832.32 | |
| 2019 | 58 | $1K | |
| 2020 | 206 | $4K | |
| 2021 | 46 | $958.70 | |
| 2022 | 22 | $744.55 | |
| 2023 | 166 | $7K | |
| 2024incomplete | 28 | $1K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 187 | 141 | $7K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 15% | 38 | 30 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 41 | 29 | $2K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.8% | 43 | 32 | $1K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 5.5% | 93 | 63 | $916.67 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.9% | 23 | 14 | $810.17 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.4% | 35 | 30 | $565.10 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.0% | 18 | 13 | $494.86 |
| 36415 | Collection of venous blood by venipuncture | 1.8% | 64 | 57 | $301.82 |
| 99072 | 0% | 20 | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.